Vimarsana
Biggest News Aggregation in the World

Page 11 - Precigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precigen Today - Breaking & Trending Today

Precigen to Announce Third Quarter 2022 Financial Results on November 9th - Vimarsana News

Precigen to Announce Third Quarter 2022 Financial Results on November 9th

Published: November 2, 2022

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Steven HarasymExchange CommissionPrnewswire Precigen IncPrecigen IncAdvancing MedicineAnnual Report
Precigen to Participate in the 2022 Wells Fargo Healthcare Conference - Vimarsana News

Precigen to Participate in the 2022 Wells Fargo Healthcare Conference

Published: September 1, 2022

/PRNewswire/ -- Precigen, Inc. (NASDAQ: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
United StatesStevenm HarasymHelen SabzevariExchange CommissionPrecigen IncFargo Healthcare ConferenceAdvancing MedicineAnnual Report
Precigen Reports Second Quarter and First Half 2022 Financial Results - Vimarsana News

Precigen Reports Second Quarter and First Half 2022 Financial Results

Published: August 8, 2022

– Enrollment complete in Phase 1 study of PRGN-3006 UltraCAR-T® in acute myeloid leukemia (AML); enrollment ongoing in Phase 1b dose expansion study; Mayo...

Source: prnewswire.com
Related Topics:
United StatesMayo Clinic In RochesterHarry Thomasian JrStevenm HarasymHelen SabzevariExchange CommissionDrug AdministrationPrecigen IncMayo ClinicDose LevelTrans Ova GeneticsDivest Non Healthcare Subsidiary Trans OvaHart Scott Rodino Antitrust Improvements ActFast TrackFirst HalfResults ComparedPrior Year PeriodAdvancing MedicineTrans OvaAnnual Report
Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics - Vimarsana News

Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics

Published: July 5, 2022

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Stevenm HarasymHelen SabzevariDavis Polk WardwellExchange CommissionPrnewswire Precigen IncRabo Securities United States IncPrecigen IncTrans Ova GeneticsTrans OvaHart Scott Rodino Antitrust Improvements ActSecurities United StatesDavis PolkAdvancing MedicineAnnual Report
Precigen to Participate in the Stifel 2022 Virtual Cell Therapy Summit - Vimarsana News

Precigen to Participate in the Stifel 2022 Virtual Cell Therapy Summit

Published: June 27, 2022

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Stevenm HarasymHelen SabzevariExchange CommissionPrnewswire Precigen IncPrecigen IncIncluding AutologousCell TherapyAdvancing MedicineAnnual ReportInvestor Relations